Intracerebroventricular administration of melanotan II increases insulin sensitivity of glucose disposal in mice

Diabetologia

Volumn 48, Issue 8, 2005, Pages 1621-1626

  Heijboer, A C ^a,b   Van Den Hoek, A M ^a,b   Pijl, H ^a   Voshol, P J ^a,b   Havekes, L M ^a,b   Romijn, J A ^a   Corssmit, E P M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TNO   (Netherlands)

Author keywords

Brain; Diabetes; Glut4; Insulin resistance; Metabolism; Neuropeptides

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 4; HORMONE RECEPTOR STIMULATING AGENT; INSULIN; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOTAN II; MESSENGER RNA; PLACEBO; TRITIUM; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN LATERAL VENTRICLE; CONTROLLED STUDY; DISTILLATION; DRUG EFFECT; FOOD INTAKE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; HYPERINSULINEMIA; INSULIN SENSITIVITY; ISOTOPE LABELING; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE;

ALPHA-MSH; ANIMALS; BLOOD GLUCOSE; CORTICOSTERONE; FATTY ACIDS, NONESTERIFIED; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORTER TYPE 4; INJECTIONS, INTRAVENTRICULAR; INSULIN; INSULIN RESISTANCE; KINETICS; LIVER; MALE; MICE; MICE, INBRED C57BL; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; PEPTIDES, CYCLIC; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTOR, MELANOCORTIN, TYPE 4; RNA, MESSENGER;

EID: 23844485943     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-1838-8     Document Type: Article

References (29)

1. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404:661-671
2. Raposinho PD, White RB, Aubert ML (2003) The melanocortin agonist Melanotan-II reduces the orexigenic and adipogenic effects of neuropeptide Y (NPY) but does not affect the NPY-driven suppressive effects on the gonadotropic and somatotropic axes in the male rat. J Neuroendocrinol 15:173-181
3. Nijenhuis WA, Oosterom J, Adan RA (2001) AgRP(SS-132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol Endocrinol 15:164-171
4. Morton GJ, Schwartz MW (2001) The NPY/AgRP neuron and energy homeostasis. Int J Obes Relat Metab Disord 25 [Suppl 5]:S56-S62
5. Hillebrand JJ, de Wied D, Adan RA (2002) Neuropeptides, food intake and body weight regulation: a hypothalamic focus. Peptides 23:2283-2306
6. Wisse BE, Schwartz MW (2001) Role of melanocortins in control of obesity. Lancet 358:857-859
7. Schwartz MW, Woods SC, Seeley RJ, Barsh GS, Baskin DG, Leibel RL (2003) Is the energy homeostasis system inherently biased toward weight gain? Diabetes 52:232-238
8. van den Hoek AM, Voshol PJ, Kamekamp BN et al (2004) Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin. Diabetes 53:2529-2534
9. Obici S, Feng Z, Tan J, Liu L, Karkanias G, Rossetti L (2001) Central melanocortin receptors regulate insulin action. J Clin Invest 108:1079-1085
10. Mizuno TM, Kelley KA, Pasinetti GM, Roberts JL, Mobbs CV (2003) Transgenic neuronal expression of proopiomelanocortin attenuates hyperphagic response to fasting and reverses metabolic impairments in leptin-deficient obese mice. Diabetes 52:2675-2683
11. Fan W, Dinulescu DM, Butler AA, Zhou J, Marks DL, Cone RD (2000) The central melanocortin system can directly regulate serum insulin levels. Endocrinology 141:3072-3079
12. Vaisse C, Clement K, Guy-Grand B, Froguel P (1998) A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 20:113-114
13. Yeo GS, Farooqi IS, Aminian S, Halsall DJ, Stanhope RG, O'Rahilly S (1998) A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 20:111-112
14. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD (1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385:165-168
15. Schioth HB, Muceniece R, Mutulis F et al (1997) Selectivity of cyclic [D-Nal7] and [D-Phe7] substituted MSH analogues for the melanocortin receptor subtypes. Peptides 18:1009-1013
16. Paxinos G, Franklin K (1997) The mouse brain in stereotaxic coordinates. Academic, San Diego
17. Murphy B, Nunes CN, Ronan JJ, Hanaway M, Fairhurst AM, Mellin TN (2000) Centrally administered MTII affects feeding, drinking, temperature, and activity in the Sprague-Dawley rat. J Appl Physiol 89:273-282
18. Voshol PJ, Jong MC, Dahlmans VE et al (2001) In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake. Diabetes 50:2585-2590
19. van den Hoek AM, Heijboer AC, Corssmit EP et al (2004) PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet. Diabetes 53:1949-1952
20. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
21. Haynes WG, Morgan DA, Djalali A, Sivitz WI, Mark AL (1999) Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 33:542-547
22. Satoh N, Ogawa Y, Katsuura G et al (1998) Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci Lett 249:107-110
23. Nonogaki K (2000) New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 43:533-549
24. Brindley DN (1995) Role of glucocorticoids and fatty acids in the impairment of lipid metabolism observed in the metabolic syndrome. Int J Obes Relat Metab Disord 19 [Suppl 1]:S69-S75
25. Lu XY, Barsh GS, Akil H, Watson SJ (2003) Interaction between alpha-melanocyte-stimulating hormone and corticotropin-releasing hormone in the regulation of feeding and hypothalamo-pituitary-adrenal responses. J Neurosci 23:7863-7872
26. Corssmit EP, Stouthard JM, Romijn JA, Endort E, Sauerwein HP (1994) Sex differences in the adaptation of glucose metabolism to short-term fasting: effects of oral contraceptives. Metabolism 43:1503-1508
27. Corssmit EP, Van Lanschot JJ, Romijn JA, Endert E, Sauerwein HP (1995) Truncal vagotomy does not affect postabsorptive glucose metabolism in humans. J Appl Physiol 79:97-101
28. Pierroz DD, Ziotopoulou M, Ungsunan L, Moschos S, Flier JS, Mantzoros CS (2002) Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. Diabetes 51:1337-1345
29. Jonsson L, Skarphedinsson JO, Skuladottir GV, Watanobe H, Schioth HB (2002) Food conversion is transiently affected during 4-week chronic administration of melanocortin agonist and antagonist in rats. J Endocrinol 173:517-523